M&A Deal Summary

Novo Holdings A/S Acquires Single Use Support

On May 15, 2024, corporate investor Novo Holdings A/S acquired packaging company Single Use Support from Pall

Acquisition Highlights
  • This is Novo Holdings A/S’s 1st transaction in the Packaging sector.
  • This is Novo Holdings A/S’s 1st transaction in Austria.

M&A Deal Summary
Date 2024-05-15
Target Single Use Support
Sector Packaging
Buyer(s) Novo Holdings A/S
Sellers(s) Pall
Deal Type Divestiture
Advisor(s) Jefferies (Financial)
E+H Eisenberger + Herzog Rechtsanwalts (Legal)

Target

Single Use Support

Kufstein, Austria
Single Use Support is a process solution provider specializing in fluid and cold chain management of drug substances. The company focuses on developing solutions to provide manufacturers with 100% safe and efficient handling, liquid transfer, freezing, and cold chain shipping of advanced therapies and biologics in pharmaceutical production. Single Use Support Gmbh was founded in 2016 and is based in Kufstein, Germany.

Search 197,704 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Novo Holdings A/S

Investor Investor Investor Investor Investor

Category Corporate Investor
Founded 1999
Size Middle-Market
Type Sector Focused
DESCRIPTION

Novo Holdings A/S is a Danish holding company and the investment arm of the Novo Nordisk Foundation. Novo Holdings' objective is to grow the assets of the Foundation and improve the lives of people around the world. In addition to investing in equity and fixed income securities, Novo Holdings pursues direct investments in life science companies. Novo Holdings A/S was established in 1999 and is headquartered in Hellerup, Denmark.

DEAL STATS #
Overall 14 of 14
Sector (Packaging) 1 of 1
Type (Divestiture) 1 of 1
Country (Austria) 1 of 1
Year (2024) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-02-05 Catalent

Somerset, New Jersey, United States

Catalent is a provider of solutions for drugs, biologics and consumer health products. Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, holds patents for softgel (e.g. “Liqui-Caps” and “Vegicaps”) and Zydis fast-dissolve technologies used in many popular prescription and over-the-counter medicine. Catalent was founded in 2007 and is based in Somerset, New Jersey.

Buy $16.5B

Seller(S) 1

SELLER

Pall

Port Washington, New York, United States
Category Company
Founded 1946
Sector Manufacturing
Employees10,400
Revenue 2.8B USD (2014)
DESCRIPTION

Pall Corp. is a provider of filtration, separation and purification products to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry.

DEAL STATS #
Overall 3 of 3
Sector (Packaging) 1 of 1
Type (Divestiture) 3 of 3
Country (Austria) 1 of 1
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-16 Single Use Support

Kufstein, Austria

Single Use Support is a process solution provider specializing in fluid and cold chain management of drug substances. The company focuses on developing solutions to provide manufacturers with 100% safe and efficient handling, liquid transfer, freezing, and cold chain shipping of advanced therapies and biologics in pharmaceutical production. Single Use Support Gmbh was founded in 2016 and is based in Kufstein, Germany.

Buy -
Mergr

Product

Company

Legal